About Jonathan Behr
Form D filings for Violet Therapeutics in 2023 list Jonathan Behr as director.
Jonathan Behr first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jonathan Behr in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Behr works with at each company, as listed on that company's latest Form D.
Violet Therapeutics, Inc. · Form D, May 5, 2023
WY
William Yelle
Executive officer and director
AU
Atsushi Usami
Director
MF
Meredith Fisher
Chief Executive Officer and director